DAC for study: "Circulating tumour DNA abundance and potential utility in de novo metastatic prostate cancer"

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001004526	We set out to determine ctDNA abundance at de novo mCSPC diagnosis and whether ctDNA provides complementary clinically relevant information to a prostate biopsy. We collected and sequenced 77 plasma cell-free DNA samples from 53 newly diagnosed patients with mCSPC. Targeted sequencing was also performed on DNA from 48 diagnostic prostate tissue samples.	Illumina HiSeq 2500	178